Att E

783

Federal Register / Vol. 81, No. 4 / Thursday, January 7, 2016 / Notices
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. 2016–00033 Filed 1–6–16; 8:45 am]
BILLING CODE 6750–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
[CFDA Number: 93.598]

Announcement of the Award of a
Single-Source Program Expansion
Supplement Grant to Heartland Human
Care Services in Chicago, IL
Office of Refugee Resettlement,
ACF, HHS.
ACTION: Announcement of the award of
a single-source program expansion
supplement to Heartland Human Care
Services (HHCS) to support expanded
services to foreign trafficking victims,
potential trafficking victims, and certain
family members.
AGENCY:

The Administration for
Children and Families (ACF), Office of
Refugee Resettlement (ORR) announces
the award of a single-source program
expansion supplement grant to
Heartland Human Care Services in
Chicago, Illinois, for a total of $144,822.
The supplemental funding will ensure
that clients’ essential needs, such as
housing, transportation,
communication, food, and medical care,
will be met.
DATES: The period of support under
these supplements is September 30,
2014 through September 29, 2015.
FOR FURTHER INFORMATION CONTACT:
Maggie Wynne, Director, Division of
Anti-Trafficking in Persons, Office of
Refugee Resettlement, 901 D Street SW.,
Washington, DC 20024, Telephone (202)
401–4664. Email: maggie.wynne@
acf.hhs.gov.
SUPPLEMENTARY INFORMATION: The
National Human Trafficking Victim
Assistance Program (NHTVAP) provides
funding for comprehensive case
management services to victims of
trafficking and certain family members
on a per capita basis. The NHTVAP
SUMMARY:

grantees help clients gain access to
housing, employability services, mental
health screening and therapy, medical
care, and some legal services. During FY
2015, a grantee, Heartland Human Care
Services (HHCS), served more clients
than it had planned for in its budget for
the year. Without the additional
funding, HHCS would have to make
significant cuts in services to current
clients and limit the enrollment of new
clients. With the supplemental funding,
HHCS will be able to ensure that all of
the clients’ essential needs will be met.
Statutory Authority: Trafficking
Victims Protection Act of 2000 (TVPA),
as amended, Section 107(b)(1)(B), 22
U.S.C. 7105(b)(1)(B), authorizes funding
for benefits and services to foreign
victims of severe forms of trafficking in
persons in the United States, potential
victims of trafficking seeking HHS
Certification, and certain family
members.
Christopher Beach,
Senior Grants Policy Specialist, Office of
Administration.
[FR Doc. 2015–33296 Filed 1–6–16; 8:45 am]
BILLING CODE 4184–47–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Comment Request
Proposed Projects: Application for
Grants to States.
Title: State Access and Visitation
Grant Application.
OMB No.: 0970–NEW.
Description: The Personal
Responsibility and Work Opportunity
Reconciliation Act of 1996 (PRWORA)
created the ‘‘Grants to States for Access
and Visitation’’ program (AV grant
program). Funding for the program
began in FY 1997 with a capped, annual
entitlement of $10 million. The
statutory goal of the program is to
provide funds to states that will enable
them to provide services for the purpose
of increasing noncustodial parent (NCP)
access to and visitation with their
children. State governors decide which

state entity will be responsible for
implementing the AV grant program in
addition to determining who will be
served, what services will be provided,
and whether the services will be
statewide or in local jurisdictions. The
statute specifies certain activities which
may be funded including: Voluntary
and mandatory mediation, counseling,
education, the development of parenting
plans, supervised visitation, and the
development of guidelines for visitation
and alternative custody arrangements.
Even though OCSE manages this
program, the funding for the AV grant
is separate from funding for federal and
state administration of the Child
Support program.
Section 469B(e)(3) of the Social
Security Act (Pub. L. 104–193) requires
that each state receiving an AV grant
award shall monitor, evaluate and
report on such programs in accordance
with regulations. Additionally, the
Catalog of Federal Domestic Assistance,
states that there is an application
requirement for Grants to States for
Access and Visitation Programs
(93.597). The application process will
assist OCSE in complying with this
requirement and will reflect a greater
emphasis on program efficiency,
coordination of services, and increased
attention to family safety.
The application will require states to
submit a program plan, indicating how
they anticipate spending their funds
within the program statue and
regulations. The applications will cover
three fiscal years and any changes made
to the plan during the three year period
will require a notification of change to
OCSE.
OCSE will review the applications to
ensure that planned services meet the
requirements laid out in Section
469B(e)(3) of the Social Security Act
(Pub. L. 104–193). This review will
include monitoring of program
compliance and the safe delivery of
services. In addition to monitoring, the
report will also assist in OCSE’s ability
to provide technical assistance to states
that would like assistance.
Respondents: Recipients of the Access
& Visitation Grant (54 states and
territories).

rmajette on DSK2TPTVN1PROD with NOTICES

ANNUAL BURDEN ESTIMATES
Instrument

Number of
respondents

Number of
responses per
respondent

Average
burden hours
per response

Total burden
hours

Fillable word document ....................................................................................

54

1

10

540

VerDate Sep<11>2014

18:26 Jan 06, 2016

Jkt 238001

PO 00000

Frm 00050

Fmt 4703

Sfmt 4703

E:\FR\FM\07JAN1.SGM

07JAN1

784

Federal Register / Vol. 81, No. 4 / Thursday, January 7, 2016 / Notices

Estimated Total Annual Burden
Hours: 540.
In compliance with the requirements
of Section 506(c)(2)(A) of the Paperwork
Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Planning, Research
and Evaluation, 370 L’Enfant
Promenade SW., Washington, DC 20447,
Attn: ACF Reports Clearance Officer.
Email address: infocollection@
acf.hhs.gov. All requests should be
identified by the title of the information
collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2016–00054 Filed 1–6–16; 8:45 am]
BILLING CODE 4184–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2015–N–4602]

Streamlining Regulations for Good
Manufacturing Practices for Hearing
Aids; Public Workshop; Request for
Comments
AGENCY:

Food and Drug Administration,

rmajette on DSK2TPTVN1PROD with NOTICES

HHS.
Notice of public workshop;
request for comments.

discussed is the appropriate level of
good manufacturing practices (GMPs)
regulation to ensure the safety and
effectiveness of air-conduction hearing
aid devices.
DATES: The public workshop will be
held on April 21, 2016, from 8:30 a.m.
to 5 p.m. Submit either electronic or
written comments on the public
workshop by May 19, 2016.
ADDRESSES: The public workshop will
be held at FDA’s White Oak Campus,
10903 New Hampshire Ave., Bldg. 31
Conference Center, the Great Room (Rm.
1503), Silver Spring, MD 20993–0002.
Entrance for the public meeting
participants (non-FDA employees) is
through Building 1 where routine
security check procedures will be
performed. For parking and security
information, please refer to http://
www.fda.gov/AboutFDA/
WorkingatFDA/BuildingsandFacilities/
WhiteOakCampusInformation/
ucm241740.htm.
You may submit comments as
follows:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal: http://
www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to http://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on http://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).

ACTION:

Written/Paper Submissions

The Food and Drug
Administration (FDA) is announcing the
following public workshop entitled
‘‘Streamlining Regulations for Good
Manufacturing Practices (GMPs) for
Hearing Aids.’’ The topic to be

Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Division of
Dockets Management (HFA–305), Food
and Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.

SUMMARY:

VerDate Sep<11>2014

18:26 Jan 06, 2016

Jkt 238001

PO 00000

Frm 00051

Fmt 4703

Sfmt 4703

• For written/paper comments
submitted to the Division of Dockets
Management, FDA will post your
comment, as well as any attachments,
except for information submitted,
marked and identified, as confidential,
if submitted as detailed in
‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2015–N–4602 for ‘‘Streamlining
Regulations for Good Manufacturing
Practices (GMPs) for Hearing Aids.’’
Received comments will be placed in
the docket and, except for those
submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
http://www.regulations.gov or at the
Division of Dockets Management
between 9 a.m. and 4 p.m., Monday
through Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
http://www.regulations.gov. Submit
both copies to the Division of Dockets
Management. If you do not wish your
name and contact information to be
made publicly available, you can
provide this information on the cover
sheet and not in the body of your
comments and you must identify this
information as ‘‘confidential.’’ Any
information marked as ‘‘confidential’’
will not be disclosed except in
accordance with 21 CFR 10.20 and other
applicable disclosure law. For more
information about FDA’s posting of
comments to public dockets, see 80 FR
56469, September 18, 2015, or access
the information at: http://www.fda.gov/
regulatoryinformation/dockets/
default.htm.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to http://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Division of Dockets
Management, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852.

E:\FR\FM\07JAN1.SGM

07JAN1